Yu-Rung Kao

592 total citations
9 papers, 446 citations indexed

About

Yu-Rung Kao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu-Rung Kao has authored 9 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu-Rung Kao's work include Lung Cancer Treatments and Mutations (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related Molecular Pathways (2 papers). Yu-Rung Kao is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related Molecular Pathways (2 papers). Yu-Rung Kao collaborates with scholars based in Taiwan. Yu-Rung Kao's co-authors include Cheng‐Wen Wu, Shine‐Gwo Shiah, Herng‐Sheng Lee, Yi‐Wen Chu, Felicia Ying-Hsiueh Wu, Yu‐Ting Chou, Cheng‐Wen Wu, Cheng‐Wen Wu, Junn-Liang Chang and Chih‐Hung Chung and has published in prestigious journals such as Cancer Research, Oncogene and Molecular Pharmacology.

In The Last Decade

Yu-Rung Kao

9 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Rung Kao Taiwan 7 198 183 174 62 57 9 446
Hye‐Kyung Jeon South Korea 12 313 1.6× 160 0.9× 140 0.8× 112 1.8× 37 0.6× 14 519
Masayo Umebayashi Japan 13 260 1.3× 187 1.0× 261 1.5× 79 1.3× 33 0.6× 37 530
Kerstin Maria Kampa-Schittenhelm Germany 12 283 1.4× 90 0.5× 171 1.0× 55 0.9× 37 0.6× 30 516
Joan Fernando Spain 7 334 1.7× 91 0.5× 192 1.1× 128 2.1× 44 0.8× 8 532
Anja Wimmel Germany 10 405 2.0× 222 1.2× 254 1.5× 51 0.8× 43 0.8× 11 596
Caren Jayasinghe Germany 10 204 1.0× 182 1.0× 286 1.6× 138 2.2× 40 0.7× 16 510
Patrick Grierson United States 14 271 1.4× 119 0.7× 206 1.2× 85 1.4× 44 0.8× 38 514
Nicole E. McNeil United States 12 312 1.6× 106 0.6× 223 1.3× 107 1.7× 34 0.6× 23 623
Angela M. Gocher United States 5 264 1.3× 320 1.7× 326 1.9× 94 1.5× 91 1.6× 7 662
Touko Inao Japan 12 184 0.9× 145 0.8× 280 1.6× 106 1.7× 71 1.2× 20 495

Countries citing papers authored by Yu-Rung Kao

Since Specialization
Citations

This map shows the geographic impact of Yu-Rung Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Rung Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Rung Kao more than expected).

Fields of papers citing papers by Yu-Rung Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Rung Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Rung Kao. The network helps show where Yu-Rung Kao may publish in the future.

Co-authorship network of co-authors of Yu-Rung Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Rung Kao. A scholar is included among the top collaborators of Yu-Rung Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Rung Kao. Yu-Rung Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hong, Shiao‐Ya, Yichun Lu, Shih-Hsin Hsiao, et al.. (2022). Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma. Oncogene. 41(13). 1907–1917. 13 indexed citations
2.
Hong, Shiao‐Ya, Yu-Rung Kao, Te‐Chang Lee, & Cheng‐Wen Wu. (2018). Abstract 3319: Epigenetic upregulation of E3 ubiquitin ligase CBLC enhances EGFR dysregulation and signaling. Cancer Research. 78(13_Supplement). 3319–3319. 1 indexed citations
3.
Hsiao, Shih-Hsin, Yu‐Ting Chou, Sey‐En Lin, et al.. (2017). Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination. Oncotarget. 8(32). 53405–53418. 15 indexed citations
4.
Lee, Ting‐Fang, Wei‐Chin Chang, Yi‐Chen Chen, et al.. (2017). YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas. Oncotarget. 8(52). 89539–89551. 16 indexed citations
5.
Chou, Yu‐Ting, Shih Sheng Jiang, Junn-Liang Chang, et al.. (2016). Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity. Cancer Research. 76(23). 7036–7048. 52 indexed citations
6.
Kao, Yu-Rung, Chih-An Lin, Paula Kuo, et al.. (2016). Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma. Oncotarget. 7(17). 24179–24193. 37 indexed citations
7.
Chou, Yu‐Ting, et al.. (2010). Abstract 274: Cited2, a novel EGFR-induced coactivator, plays a key role in lung cancer progression. Cancer Research. 70(8_Supplement). 274–274. 1 indexed citations
8.
Kao, Yu-Rung, et al.. (2005). Expression of Axl in Lung Adenocarcinoma and Correlation with Tumor Progression. Neoplasia. 7(12). 1058–1064. 221 indexed citations
9.
Kao, Yu-Rung, et al.. (2003). Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram. Molecular Pharmacology. 64(5). 1076–1084. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026